Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics
Expert Opin Drug Metab Toxicol
.
2023 Jul-Dec;19(11):733-739.
doi: 10.1080/17425255.2023.2277758.
Epub 2023 Nov 17.
Authors
Allegra Sarah
1
,
Emma Dondi
1
,
Silvia De Francia
1
Affiliation
1
Department of Clinical and Biological Sciences, University of Turin, S. Luigi Gonzaga Hospital, Orbassano, TO, Italy.
PMID:
37916644
DOI:
10.1080/17425255.2023.2277758
No abstract available
Keywords:
Cancer; Chemotherapy; Personalized Treatment; Precision Medicine.
Publication types
Editorial
MeSH terms
Humans
Pharmacogenetics*
Precision Medicine
Tyrosine Kinase Inhibitors*
Substances
Tyrosine Kinase Inhibitors